Sabitlenmiş Tweet
PhRMA
16.9K posts
PhRMA
@PhRMA
Representing America’s biopharma & biotech companies. Shaping policy so science thrives & patients benefit.
Washington, DC Katılım Şubat 2010
52 Takip Edilen80.3K Takipçiler
At this week’s #HillNationSummit, PhRMA COO @lreilly71 discussed what's needed to keep America the global leader in biopharmaceutical innovation—from strengthening our innovation ecosystem to ensuring patients continue to have first access to new medicines.
Lori Reilly@lreilly71
Enjoyed joining yesterday’s #HillNationSummit with @KathleenKoch1 to discuss how America's biopharmaceutical industry strengthens our economy, our health security and our global competitiveness. Protecting the policies that fuel innovation will help ensure patients continue to benefit from the next generation of medicines. @TheHillEvents
English
Made up terms like "patent thickets" and "evergreening," share one thing: none of them hold up to scrutiny. The evidence has debunked each one. But because they continue to come up, it’s time to correct the record.
Read more: ow.ly/yoBv50Zoi2X
English
Fortunately, policymakers in both parties have started cracking down on abusive practices from PBMs.
But making medicine more affordable requires building on these efforts with additional reforms.
Check out @RobZirk’s new op-ed in @thehill on how the work continues ⬇️
Robert Zirkelbach@robzirk
Today, I shared my thoughts in @thehill: Our health care system is dominated by a handful of vertically integrated conglomerates that can block patients' access to more affordable medicine options to boost their own profits. Read my full op-ed: thehill.com/opinion/health…
English
Global competition for biopharmaceutical innovation is accelerating.
On @decidersshow, hosts @BrodyMullinsDC and @camoosomiller spoke with our CEO @steveubl about why the U.S. must continue to strengthen research, investment and clinical development to maintain its leadership.
English
Some of today's medical breakthroughs would have seemed unimaginable just a generation ago.
On @decidersshow, PhRMA President and CEO @steveubl joined @BrodyMullinsDC and @camoosomiller to discuss how medical innovation is transforming lives and why policies that support innovation matter.
ow.ly/iuqn50Znli1
English
Patients want affordable care and timely access to the medicines their doctors prescribe.
Our latest guest blog from Lauren Bumgardner Current, a Voters for Cures patient advocate from North Carolina, explains why price controls won’t solve the challenges she faces to get her medicines.
Read more: ow.ly/lnqV50ZmVgF
English
Compounded drugs aren’t FDA-approved—and the rise of mass-produced “personalized” knockoffs should concern everyone. Aggressive marketing downplays real risks. The FDA and policymakers must continue to act to stop bad actors who bypass approvals and put patient safety at risk.
English
For 250 years, America has championed innovation. 🇺🇸
By protecting invention and rewarding risk, our nation built an innovation ecosystem that continues to drive breakthroughs for patients and strengthen American leadership.
The result? An innovation ecosystem that is the envy of the world.
English
How did America become the world's leading engine for medical innovation?
In a new op-ed with @RealClearHealth, our CEO @steveubl explores how 250 years of smart policy choices helped build America's biopharmaceutical edge—and why protecting that foundation matters for the next generation of cures.
ow.ly/8RVj50ZjIjJ
English
There are no rules on how some big hospital systems use 340B profits and patients and taxpayers are paying the price.
“If they want to put a chandelier in their waiting room, they can.”
More from Fox Business on why policymakers are pushing for transparency and accountability. ⬇️
English